News

Prostate Health(83)

RSS FEED

Jan10

Nanotechnology providing breakthroughs in prostate cancer treatment

Chemotherapy has been the primary means of treating malignant cancers for decades, but doctors have always been stuck with the problem of certain cancer cells that won't accept the drugs. According to HealthJockey.com, scientists at Brigham and Women's Hospital have used nanotechnology to deliver chemotherapy drugs directly to prostate cancer cells to eliminate them.

According to the Center for Responsible Nanotechnology, the practice refers to the direct engineering of functional systems at a cellular or molecular level. Essentially, it refers to building things from the bottom up, and this is especially intriguing in cancer treatment where certain drugs can be programmed to attack specific cells.

"In this study we developed a unique strategy that enables the nanoparticles to specifically target and efficiently be engulfed into any desired types and sub-types of cancer cells, even if their cancer markers are unknown," Zeyu Xiao, a BWH researcher, told the news source.

While these studies are certainly groundbreaking, men can reduce their risk of prostate cancer by taking Clinician's Choice Prostate Guardian each day. This supplement is formulated with a wide range of nutrients designed to foster good prostate health and size.

About Clinicians Choice

Clinicians Choice takes a holistic approach in addressing the body's nutritional deficiencies, based on gender, age and how science confirms the body works. We formulate an interrelated family of products meant to be taken together and complement each other. Ingredient selection, expert formulation, manufacturing and quality assurance are essential steps that we diligently take when making the finest quality supplements.